{"id":"https://openalex.org/W4393073292","doi":"https://doi.org/10.1158/1538-7445.am2024-4554","title":"Abstract 4554: Novel combination therapy for treating proteasome inhibitor-resistant multiple myeloma","display_name":"Abstract 4554: Novel combination therapy for treating proteasome inhibitor-resistant multiple myeloma","publication_year":2024,"publication_date":"2024-03-22","ids":{"openalex":"https://openalex.org/W4393073292","doi":"https://doi.org/10.1158/1538-7445.am2024-4554"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2024-4554","doi":"https://doi.org/10.1158/1538-7445.am2024-4554","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.am2024-4554","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5018875127","display_name":"Byung\u2010Gyu Kim","orcid":"https://orcid.org/0000-0002-8921-5061","observed_orcids":["https://orcid.org/0000-0002-8921-5061"]},"institutions":[{"id":"https://openalex.org/I58956616","display_name":"Case Western Reserve University","ror":"https://ror.org/051fd9666","country_code":"US","type":"education","lineage":["https://openalex.org/I58956616"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Byung-Gyu Kim","raw_affiliation_strings":["1Case Western Reserve University School of Medicine, Cleveland, OH;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Case Western Reserve University School of Medicine, Cleveland, OH;","institution_ids":["https://openalex.org/I58956616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101707512","display_name":"Sung Hee Choi","orcid":"https://orcid.org/0000-0002-8102-5538","observed_orcids":["https://orcid.org/0000-0002-8102-5538"]},"institutions":[{"id":"https://openalex.org/I58956616","display_name":"Case Western Reserve University","ror":"https://ror.org/051fd9666","country_code":"US","type":"education","lineage":["https://openalex.org/I58956616"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sung Hee Choi","raw_affiliation_strings":["1Case Western Reserve University School of Medicine, Cleveland, OH;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Case Western Reserve University School of Medicine, Cleveland, OH;","institution_ids":["https://openalex.org/I58956616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034712900","display_name":"Huong Nguyen","orcid":"https://orcid.org/0000-0002-5989-1405","observed_orcids":["https://orcid.org/0000-0002-5989-1405"]},"institutions":[{"id":"https://openalex.org/I58956616","display_name":"Case Western Reserve University","ror":"https://ror.org/051fd9666","country_code":"US","type":"education","lineage":["https://openalex.org/I58956616"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Huong Nguyen","raw_affiliation_strings":["1Case Western Reserve University School of Medicine, Cleveland, OH;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Case Western Reserve University School of Medicine, Cleveland, OH;","institution_ids":["https://openalex.org/I58956616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050000925","display_name":"Fu\u2010Sen Liang","orcid":"https://orcid.org/0000-0002-1793-0824","observed_orcids":["https://orcid.org/0000-0002-1793-0824"]},"institutions":[{"id":"https://openalex.org/I58956616","display_name":"Case Western Reserve University","ror":"https://ror.org/051fd9666","country_code":"US","type":"education","lineage":["https://openalex.org/I58956616"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Fu-Sen Liang","raw_affiliation_strings":["1Case Western Reserve University School of Medicine, Cleveland, OH;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Case Western Reserve University School of Medicine, Cleveland, OH;","institution_ids":["https://openalex.org/I58956616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100321802","display_name":"Seong\u2010Jin Kim","orcid":"https://orcid.org/0000-0001-9701-0632","observed_orcids":["https://orcid.org/0000-0001-9701-0632"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Seong-Jin Kim","raw_affiliation_strings":["2MedPacto, Seoul, Republic of Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2MedPacto, Seoul, Republic of Korea","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091034692","display_name":"John J. Letterio","orcid":"https://orcid.org/0000-0003-0437-6323","observed_orcids":["https://orcid.org/0000-0003-0437-6323"]},"institutions":[{"id":"https://openalex.org/I58956616","display_name":"Case Western Reserve University","ror":"https://ror.org/051fd9666","country_code":"US","type":"education","lineage":["https://openalex.org/I58956616"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Letterio","raw_affiliation_strings":["1Case Western Reserve University School of Medicine, Cleveland, OH;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Case Western Reserve University School of Medicine, Cleveland, OH;","institution_ids":["https://openalex.org/I58956616"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5025536959","display_name":"Alex Yee-Chen Huang","orcid":"https://orcid.org/0000-0002-5701-4521","observed_orcids":["https://orcid.org/0000-0002-5701-4521"]},"institutions":[{"id":"https://openalex.org/I58956616","display_name":"Case Western Reserve University","ror":"https://ror.org/051fd9666","country_code":"US","type":"education","lineage":["https://openalex.org/I58956616"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alex Huang","raw_affiliation_strings":["1Case Western Reserve University School of Medicine, Cleveland, OH;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Case Western Reserve University School of Medicine, Cleveland, OH;","institution_ids":["https://openalex.org/I58956616"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"84","issue":"6_Supplement","first_page":"4554","last_page":"4554"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11501","display_name":"TGF-\u03b2 signaling in diseases","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11041","display_name":"Ubiquitin and proteasome pathways","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9869999885559082},{"id":"https://openalex.org/keywords/proteasome-inhibitor-resistance","display_name":"proteasome inhibitor resistance","score":0.9850000143051147},{"id":"https://openalex.org/keywords/vactosertib","display_name":"vactosertib","score":0.9330000281333923},{"id":"https://openalex.org/keywords/bortezomib-resistance","display_name":"bortezomib resistance","score":0.9480000138282776},{"id":"https://openalex.org/keywords/ixazomib","display_name":"ixazomib","score":0.9929999709129333},{"id":"https://openalex.org/keywords/psmb5","display_name":"PSMB5","score":0.9179999828338623},{"id":"https://openalex.org/keywords/smad2-3-signaling","display_name":"Smad2/3 signaling","score":0.9559999704360962},{"id":"https://openalex.org/keywords/myeloid-derived-suppressor-cells","display_name":"myeloid-derived suppressor cells","score":0.9409999847412109},{"id":"https://openalex.org/keywords/regulatory-t-cells","display_name":"regulatory T cells","score":0.9879999756813049},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.9350000023841858},{"id":"https://openalex.org/keywords/bcma-car-t-cells","display_name":"BCMA CAR T cells","score":0.9549999833106995},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.9890000224113464},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.5690000057220459}],"concepts":[{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.8215663433074951},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5542101263999939},{"id":"https://openalex.org/C2778367456","wikidata":"https://www.wikidata.org/wiki/Q7251235","display_name":"Proteasome inhibitor","level":3,"score":0.5128839015960693},{"id":"https://openalex.org/C27740335","wikidata":"https://www.wikidata.org/wiki/Q14878333","display_name":"Proteasome","level":2,"score":0.4341888129711151},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3760778605937958},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2390260398387909},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.17320749163627625},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.051674991846084595}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2024-4554","doi":"https://doi.org/10.1158/1538-7445.am2024-4554","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.am2024-4554","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9922999739646912,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4313423607","https://openalex.org/W2914590646","https://openalex.org/W2911265924","https://openalex.org/W4386270923","https://openalex.org/W2986512953","https://openalex.org/W4405054035","https://openalex.org/W4401905223","https://openalex.org/W4389235196","https://openalex.org/W4249088156","https://openalex.org/W3170263819"],"abstract_inverted_index":{"Abstract":[0],"Multiple":[1],"myeloma":[2,294],"(MM)":[3],"is":[4],"an":[5],"incurable":[6],"plasma":[7],"cell":[8,258],"malignancy":[9],"characterized":[10],"by":[11,96,114,196],"osteolytic":[12],"bone":[13,155],"disease":[14,52],"and":[15,31,55,102,127,141,161,200,207,247,254,264],"immunosuppression.":[16],"Proteasome":[17],"inhibitors":[18],"(PIs)":[19],"have":[20],"remarkably":[21],"improved":[22],"the":[23,32,61,81,108,130,145,163,172,238,299],"survival":[24,199],"of":[25,34,65,77,83,100,104,118,129,147,165,176,211,243,252,298],"MM":[26,45,86,125,246],"patients,":[27],"but":[28],"dose-limiting":[29],"toxicities":[30],"development":[33],"drug":[35,50,262],"resistance":[36,263],"limit":[37],"their":[38],"long-term":[39],"utility.":[40],"Elevated":[41],"TGF-\u03b2":[42,67,98],"levels":[43],"in":[44,88,154,171,204,216,245],"patient":[46,267],"sera":[47],"correlate":[48],"with":[49,90,218],"resistance,":[51],"progression,":[53],"metastasis":[54],"poor":[56],"prognosis.":[57],"Therefore,":[58],"we":[59],"evaluated":[60],"anti-MM":[62],"therapeutic":[63],"potential":[64],"a":[66,121,184,202,221],"type":[68],"I":[69],"receptor":[70],"kinase":[71],"inhibitor,":[72],"Vactosertib.":[73,232],"In":[74],"vitro":[75],"treatment":[76],"Vactosertib":[78,119,135,177,192,219,244,253],"synergistically":[79],"inhibited":[80],"growth":[82],"bortezomib":[84],"(BTZ)-resistant":[85],"cells":[87,152,169,215,230],"combination":[89,217,251,287],"either":[91,191,227,255],"BTZ":[92],"or":[93,181,193,231,257],"ixazomib":[94],"(IXZ)":[95],"suppressing":[97],"activation":[99],"Smad2/3":[101],"expression":[103,140],"PSMB5,":[105],"which":[106],"encodes":[107],"proteasome":[109,142,291],"5":[110],"catalytic":[111],"subunit":[112],"targeted":[113],"PIs.":[115],"Oral":[116],"administration":[117],"as":[120],"single":[122],"agent":[123],"decreased":[124],"progression":[126],"mortality":[128],"mice":[131],"bearing":[132],"BTZ-resistant":[133],"MM.":[134],"alone":[136,195],"also":[137],"attenuated":[138],"PSMB5":[139],"activity,":[143],"reduced":[144],"expansion":[146],"CD11b+Gr-1+":[148],"myeloid":[149],"derived":[150],"suppressor":[151],"(MDSCs)":[153],"marrow":[156],"(BM)":[157],"tumor":[158],"microenvironment":[159],"(TME),":[160],"diminished":[162],"population":[164],"Foxp3+":[166],"regulatory":[167],"T":[168,214,229],"(Treg)":[170],"spleen.":[173],"Combination":[174],"therapy":[175,210,259,288],"plus":[178],"PI":[179,194,256],"(BTZ":[180],"IXZ)":[182],"exhibited":[183,220],"synergistic":[185,222],"anti-myeloma":[186],"effect":[187],"when":[188],"compared":[189,225],"to":[190,226],"greatly":[197],"prolonged":[198],"significant":[201],"reduction":[203],"both":[205],"MDSCs":[206],"Tregs.":[208],"Furthermore,":[209],"BCMA+":[212],"CAR":[213,228],"anti-tumor":[223],"effect,":[224],"Taken":[233],"together,":[234],"our":[235],"data":[236],"provide":[237],"rationale":[239],"for":[240,289,302],"clinical":[241],"evaluation":[242],"demonstrate":[248],"proof-of-concept":[249],"that":[250],"may":[260],"overcome":[261],"enhance":[265],"durable":[266],"responses.":[268],"Citation":[269],"Format:":[270],"Byung-Gyu":[271],"Kim,":[272,281],"Sung":[273],"Hee":[274],"Choi,":[275],"Huong":[276],"Nguyen,":[277],"Fu-Sen":[278],"Liang,":[279],"Seong-Jin":[280],"John":[282],"Letterio,":[283],"Alex":[284],"Huang.":[285],"Novel":[286],"treating":[290],"inhibitor-resistant":[292],"multiple":[293],"[abstract].":[295],"In:":[296],"Proceedings":[297],"American":[300],"Association":[301],"Cancer":[303,321],"Research":[304],"Annual":[305],"Meeting":[306],"2024;":[307],"Part":[308],"1":[309],"(Regular":[310],"Abstracts);":[311],"2024":[312],"Apr":[313],"5-10;":[314],"San":[315],"Diego,":[316],"CA.":[317],"Philadelphia":[318],"(PA):":[319],"AACR;":[320],"Res":[322],"2024;84(6_Suppl):Abstract":[323],"nr":[324],"4554.":[325]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2024-03-23T00:00:00"}